Toggle navigation
Products
Drug Impurities Reference Standards
Drug Substance Reference Standards
Drug Substance Stable Isotope Labeled Reference Standards
Drug Metabolites Reference Standards
Drug Metabolites Stable Isotope Labeled Reference Standards
Fine Labeled Research Chemicals
Fine Research Chemicals
Services
Custom Synthesis
Research Projects
Company
About Us
Distributors
Careers
ARI Blog
Support
Contact Us
Request a Quote
Request COA/MSDS
Alogliptin
Home
/
Products
/
Drug Substance Reference Standards
/ Alogliptin
Products
>
Drug Substance Reference Standards
>
Alogliptin
Product Information
Product Number
ALG-15-001
Catalog Number
ALG-15-001
Molecular Formula
C18H21N5O2
CAS Number
850649-62-6
Parent Drug
Alogliptin
Category
Drug Substance Reference Standards
Alogliptin
Pricing & Availability
Unit Size
Choose an option
100 mg
Clear
Looking for a larger size or custom packaging configuration?
UNIT PRICE
Quantity
Order Online
Made to Order -
Lead Time: 4 to 6 week(s)
Submit Orders by Email:
orders@acanthusresearch.com
Call Us to Place an Order at
1-647-478-1021
Request a Quote
SKU:
1917
Category:
Drug Substance Reference Standards
Documentation & Safety
Request Documentation on this Product
+
Synonyms -
2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}methyl)benzonitrile
Nesina
Vipidia
IMPROVE YOUR RESEARCH & TESTING WITH HIGH QUALITY, TRACEABLE REFERENCE STANDARDS
Additional information
Additional information
Unit Size
100 mg
Related Products
Alogliptin Impurity 1
Product Number
CT-01110-344
Parent Drug
Alogliptin
CAS Number
N/A
Category
Drug Impurities Reference Standards
Pending QC
See more size options
Alogliptin-13C,D3
Product Number
ALG-15-002
Parent Drug
Alogliptin
CAS Number
1246817-18-4
Category
Drug Substance Stable Isotope Labeled Reference Standards
Made to Order -
Lead Time: 4 to 6 week(s)
See more size options
+
Synonyms -
2-({6-[(3R)-3-aminopiperidin-1-yl]-3-(13C,2H3)methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}methyl)benzonitrile
GET UPDATES FROM ACANTHUS RESEARCH
Leave this field empty if you're human: